Primary |
Fungal Infection |
20.6% |
Bronchopulmonary Aspergillosis |
11.8% |
Pneumonia |
8.1% |
Infection |
6.6% |
Systemic Candida |
6.6% |
Febrile Neutropenia |
5.9% |
Infection Prophylaxis |
5.9% |
Fungaemia |
4.4% |
Drug Use For Unknown Indication |
3.7% |
Allogenic Bone Marrow Transplantation Therapy |
2.9% |
Atrial Fibrillation |
2.9% |
Pneumonia Bacterial |
2.9% |
Aspergillosis |
2.2% |
Bone Marrow Transplant |
2.2% |
Candida Sepsis |
2.2% |
Candidiasis |
2.2% |
Fungal Peritonitis |
2.2% |
Gastritis |
2.2% |
Mediastinitis |
2.2% |
Pneumonia Aspiration |
2.2% |
|
Liver Disorder |
9.7% |
White Blood Cell Count Decreased |
9.7% |
Pyrexia |
8.3% |
Renal Failure |
6.9% |
Sepsis |
6.9% |
Ventricular Tachycardia |
6.9% |
Renal Impairment |
5.6% |
Shock |
5.6% |
Agranulocytosis |
4.2% |
Death |
4.2% |
Jaundice |
4.2% |
Renal Disorder |
4.2% |
Stevens-johnson Syndrome |
4.2% |
Condition Aggravated |
2.8% |
Dysgeusia |
2.8% |
Multi-organ Failure |
2.8% |
Oliguria |
2.8% |
Pancreatitis Acute |
2.8% |
Pneumonia Staphylococcal |
2.8% |
Refractoriness To Platelet Transfusion |
2.8% |
|
Secondary |
Drug Use For Unknown Indication |
24.6% |
Fungal Infection |
11.4% |
Bone Marrow Transplant |
7.9% |
Disseminated Intravascular Coagulation |
6.1% |
Brain Abscess |
5.3% |
Bronchopulmonary Aspergillosis |
5.3% |
Cardiac Failure |
5.3% |
Pneumonia |
5.3% |
Candidiasis |
4.4% |
Fungaemia |
4.4% |
Antifungal Prophylaxis |
3.5% |
Sepsis |
3.5% |
Acute Respiratory Distress Syndrome |
2.6% |
Acute Graft Versus Host Disease |
1.8% |
Graft Versus Host Disease |
1.8% |
Immunosuppressant Drug Therapy |
1.8% |
Rheumatoid Arthritis |
1.8% |
White Blood Cell Count Decreased |
1.8% |
Interstitial Lung Disease |
0.9% |
Liver Transplant |
0.9% |
|
Thrombotic Microangiopathy |
13.3% |
Thirst |
10.0% |
Drug Ineffective |
6.7% |
Pancreatitis Acute |
6.7% |
Renal Failure |
6.7% |
Shock |
6.7% |
Systemic Mycosis |
6.7% |
Altered State Of Consciousness |
3.3% |
Brain Abscess |
3.3% |
Bronchopulmonary Aspergillosis |
3.3% |
Disseminated Intravascular Coagulation |
3.3% |
Pneumonia |
3.3% |
Pyrexia |
3.3% |
Renal Abscess |
3.3% |
Renal Impairment |
3.3% |
Respiratory Disorder |
3.3% |
Supraventricular Tachycardia |
3.3% |
Upper Respiratory Tract Inflammation |
3.3% |
Ventricular Fibrillation |
3.3% |
Ventricular Tachycardia |
3.3% |
|
Concomitant |
Bone Marrow Transplant |
39.3% |
Renal And Pancreas Transplant |
10.7% |
Liver Transplant |
7.4% |
Stem Cell Transplant |
6.6% |
Fungal Infection |
4.9% |
Renal Transplant |
4.9% |
Acute Lymphocytic Leukaemia |
4.1% |
Rheumatoid Arthritis |
4.1% |
Cord Blood Transplant Therapy |
2.5% |
Drug Use For Unknown Indication |
2.5% |
Febrile Neutropenia |
2.5% |
Systemic Candida |
2.5% |
Bone Marrow Conditioning Regimen |
1.6% |
Herpes Simplex |
1.6% |
Acute Graft Versus Host Disease |
0.8% |
Allogenic Bone Marrow Transplantation Therapy |
0.8% |
Bone Marrow Disorder |
0.8% |
Cytomegalovirus Infection |
0.8% |
Encephalitis Herpes |
0.8% |
Staphylococcal Infection |
0.8% |
|
Thrombotic Microangiopathy |
22.0% |
Serum Ferritin Increased |
8.0% |
Vomiting |
8.0% |
White Blood Cell Count Decreased |
8.0% |
Respiratory Failure |
6.0% |
Cytomegalovirus Test Positive |
4.0% |
Pneumonia |
4.0% |
Pneumonia Bacterial |
4.0% |
Pneumonia Cytomegaloviral |
4.0% |
Renal Impairment |
4.0% |
Reversible Posterior Leukoencephalopathy Syndrome |
4.0% |
Sepsis |
4.0% |
Shock |
4.0% |
Tremor |
4.0% |
Cytomegalovirus Infection |
2.0% |
Hyperamylasaemia |
2.0% |
Interstitial Lung Disease |
2.0% |
Oral Candidiasis |
2.0% |
Pneumocystis Jiroveci Pneumonia |
2.0% |
Pyrexia |
2.0% |
|